We are live on ! Find out more
NRC icon

NRC Health Common Stock

78 hedge funds and large institutions have $278M invested in NRC Health Common Stock in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 15

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

45% more capital invested

Capital invested by funds: $192M → $278M (+$85.7M)

5% more funds holding

Funds holding: 7478 (+4)

1.09% less ownership

Funds ownership: 31.3%30.21% (-1.1%)

Holders
78
Holders Change
+4
Holders Change %
+5.41%
% of All Funds
1.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
38
Reduced
15
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Kayne Anderson Rudnick Investment Management
1
Kayne Anderson Rudnick Investment Management
California
$96.6M +$9.75M +279,760 +12%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$27M +$3.15M +90,467 +14%
BlackRock
3
BlackRock
New York
$22.2M +$4.21M +120,731 +25%
CCA
4
Conestoga Capital Advisors
Pennsylvania
$18.3M +$3.41M +97,900 +25%
Vanguard Group
5
Vanguard Group
Pennsylvania
$18.1M +$5.56M +159,492 +49%
Renaissance Technologies
6
Renaissance Technologies
New York
$14.4M +$1.35M +38,800 +11%
SC
7
Spitfire Capital
California
$13M +$1.67M +47,886 +16%
RA
8
Royce & Associates
New York
$8.61M +$178K +5,109 +2%
State Street
9
State Street
Massachusetts
$6.66M +$267K +7,654 +4%
Northern Trust
10
Northern Trust
Illinois
$6.44M +$900K +25,828 +18%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$4.74M +$1.1M +31,488 +33%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$4.07M +$382K +10,961 +11%
WA
13
Wasatch Advisors
Utah
$2.94M +$186K +5,353 +7%
Brown Advisory
14
Brown Advisory
Maryland
$2.58M +$2.4M +68,900 New
WIC
15
Willis Investment Counsel
Georgia
$2.43M +$513K +14,724 +29%
Charles Schwab
16
Charles Schwab
California
$2.12M +$458K +13,146 +30%
Comerica Bank
17
Comerica Bank
Texas
$1.91M -$106K -3,055 -5%
Ameriprise
18
Ameriprise
Minnesota
$1.9M -$31K -890 -2%
Bessemer Group
19
Bessemer Group
New Jersey
$1.77M +$212K +6,077 +15%
Morgan Stanley
20
Morgan Stanley
New York
$1.53M -$271K -7,767 -16%
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$1.34M -$156K -4,485 -11%
IP
22
Isthmus Partners
Wisconsin
$1.3M +$143K +4,096 +13%
US Bancorp
23
US Bancorp
Minnesota
$1.22M +$469K +13,459 +70%
OSAM
24
O'Shaughnessy Asset Management
Connecticut
$1.12M -$206K -5,925 -16%
Neuberger Berman Group
25
Neuberger Berman Group
New York
$1.11M -$22.4K -642 -2%

NRC Hedge Fund Activity: Q2 2018 in Review

78 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q2 2018, worth a combined $278M — up 45% from $192M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NRC positions and 5 closed out — a net gain of 4 holders — while 38 added to existing stakes and 15 trimmed.

The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $9.75M. The largest seller was WCM Investment Management, exiting entirely with an estimated $2.13M sold.

  • 78 institutional investors held NRC Health Common Stock (NRC) as of Q2 2018, up from 74 in Q1 2018.
  • Funds reported $278M of NRC Health Common Stock stock for Q2 2018, up 45% quarter-over-quarter.
  • 9 funds opened new NRC Health Common Stock positions in Q2 2018 and 5 closed out, a net change of +4 holders.
  • The largest NRC Health Common Stock buyer in Q2 2018 was Kayne Anderson Rudnick Investment Management, an estimated $9.75M added.
  • The largest NRC Health Common Stock seller in Q2 2018 was WCM Investment Management, an estimated $2.13M sold.

Based on aggregated 13F filings for Q2 2018.